Last update 08 May 2025

Chk1 x DNA

Basic Info

Related Targets
Chk1DNA

Related

1
Drugs associated with Chk1 x DNA
BBI-355
Target
Chk1 x DNA
Mechanism
Chk1 inhibitors [+1]
Active Org.
Boundless Bio, Inc.Boundless Bio, Inc.
Originator Org.
Boundless Bio, Inc.Boundless Bio, Inc.
Active Indication
Bladder Cancer [+8]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Chk1 x DNA
NCT05827614
/ RecruitingPhase 1
An Open-Label, Multicenter, First-in-Human, Dose-Escalation and Dose-Expansion, Phase 1/2 Study of BBI-355 and BBI-355 in Combination with Select Targeted Therapies in Subjects with Locally Advanced or Metastatic Solid Tumors with Oncogene Amplifications
100 Clinical Results associated with Chk1 x DNA
Login to view more data
100 Translational Medicine associated with Chk1 x DNA
Login to view more data
0 Patents (Medical) associated with Chk1 x DNA
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free